Certara said this week that it has signed a partnership with ChemAxon that will allow it to provide its customers with access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle through its D360 solution.

Certara’s D360 is an integrated solution for querying, analyzing, and visualization scientific data used by pharmaceutical and biotech companies to access data sources for drug discovery and development. This agreement will provide D360 customers with MarvinSketch, which is a chemical structure sketching tool, and the JChem Chemistry data cartridge.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.